Catapult Pharmacology
Long Acting Insulin
Insulin is used in the treatment of both type I and type II diabetes. Insulin treats these conditions by increasing uptake of serum glucose into cells, which lowers plasma glucose levels. Insulin comes in short-acting, intermediate-acting, and long-acting forms. Care must be taken on dosing to avoid hypoglycemic states, which can result in seizures and coma. Potassium shifts into cells with administration of insulin, so hypokalemia can result from administration.
Class Drugs
Insulin Glargine
Insulin Detemir
Insulin Degludec
Class Mechanism of Action
Mostly constant action over the course of 18 to 24 hours
Insulin increases uptake of serum glucose into cells, which lowers plasma glucose levels
Insulin receptor is a transmembrane tyrosine kinase receptor
Receptor activation results in glucose transporters moving from the cytoplasm to the cell membrane, which promotes glucose uptake.
Long-acting insulin begin working in 1-2 hours and last for 12-24 hours.
Class Applications
Diabetes mellitus
- Provides baseline glycemic control
Class Adverse Effects
Hypoglycemia
Injection site reactions
Drug Table
| Drug Name | Application | Comments | Image |
|---|---|---|---|
| Insulin Glargine | Pharmacokinetics; No Peak Effect | "Large G" | |
| Insulin Detemir | Pharmacokinetics; Slowly rises to peak at about 12 hours after injection, then decreases | "Determinant Tomato" | |
| Insulin Degludec | "De-glue" "Deck of Cards" |